Delivery Order SPE2DB20D2104-SPE2DB25FMPCS

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $33,116.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a completion date of March 4, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling...
This federal contract award, valued at $2,302.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a performance period extending to July 25, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $3,003.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a ceiling value of $12,477.09 and a completion date of March 25, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,267.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a completion date of March 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $3,450.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which is valued at $999,999,999 and runs through November 2026. The contract covers the procurement of medical commodities, including specialty medications, brand-name and...
The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,106.12 firm fixed-price delivery order is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product, with a completion date of October 15, 2024. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a $3,361.87 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a period of performance through April 18, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,565.49, is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product. It is a firm fixed-price delivery order contract with an ultimate completion date of April 1, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $4,322.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a completion date of January 16, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMPCS
    Delivery Order

This federal contract award, valued at $3,626.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product, with a performance period ending on April 23, 2025.

The contract is a Delivery Order placed under Amerisourcebergen Drug Corp's existing Indefinite Delivery Contract (IDC) with the DLA, designated as SPE2DX, which has a ceiling value of $999,999,999.00 and a performance period through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

The contract award does not have a set-aside designation, indicating open competition. As a prime contractor, Amerisourcebergen Drug Corp is responsible for fulfilling the requirements of this delivery order, which involves providing the specified pharmaceutical product to the DLA.

Generated 7/22/25, 10:11 AM